Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Apogee Therapeutics, Inc. - Common Stock (NQ: APGE ) 54.49 +2.45 (+4.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Apogee Therapeutics, Inc. - Common Stock < Previous 1 2 Next > Apogee Therapeutics Announces Results Up to 9 Months from Phase 1 Trial of APG777, its Novel Half-Life Extended Anti-IL-13 Antibody for the Treatment for Atopic Dermatitis and Other Inflammatory Diseases October 24, 2024 From Apogee Therapeutics Via GlobeNewswire Apogee Therapeutics Announces Poster Presentation at the ACAAI 2024 Annual Scientific Meeting October 16, 2024 From Apogee Therapeutics Via GlobeNewswire Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit September 12, 2024 From Apogee Therapeutics Via GlobeNewswire Apogee Therapeutics Appoints Jeff S. Hartness as Chief Commercial Officer September 09, 2024 From Apogee Therapeutics Via GlobeNewswire Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases August 19, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire APGE Stock Earnings: Apogee Therapeutics Meets EPS for Q2 2024 August 12, 2024 APGE stock results show that Apogee Therapeutics met analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2024 Financial Results August 12, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors July 18, 2024 From NewAmsterdam Pharma N.V. Via GlobeNewswire XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details July 14, 2024 10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit... Via Benzinga Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday July 11, 2024 Via Benzinga Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD May 28, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Apogee Therapeutics to Participate in Upcoming June Investor Conferences May 23, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases May 15, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire APGE Stock Earnings: Apogee Therapeutics Misses EPS for Q1 2024 May 13, 2024 APGE stock results show that Apogee Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results May 13, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Earnings Superstars: 3 Stocks Primed to Outperform This Quarter May 08, 2024 Discover how Nvidia, Apogee Therapeutics and JD.com stand out as earnings outperformers in their respective sectors. Via InvestorPlace Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference May 06, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases March 25, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Top 3 Health Care Stocks That Are Ticking Portfolio Bombs March 14, 2024 As of March 14, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. Via Benzinga Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million March 12, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering March 07, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire APGE Stock Earnings: Apogee Therapeutics Beats EPS for Q4 2023 March 05, 2024 APGE stock results show that Apogee Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering March 05, 2024 From Apogee Therapeutics, LLC Via GlobeNewswire Crude Oil Down 1%; Dave Shares Jump After Q4 Results March 05, 2024 U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 350 points on Tuesday. The Dow traded down 0.91% to 38,633.24 while the NASDAQ fell 1.85% to 15,906.92. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 05, 2024 Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session March 05, 2024 Via Benzinga Nasdaq Down 250 Points; ISM Services PMI Falls In February March 05, 2024 U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 250 points on Tuesday. The Dow traded down 0.64% to 38,741.00 while the NASDAQ fell 1.64% to 15,942.27. The... Via Benzinga Topics Stocks Exposures US Equities Why Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday? March 05, 2024 Apogee Therapeutics unveils promising Phase 1 data for APG777, a lead candidate for atopic dermatitis treatment. Interim results show sustained biomarker inhibition and favorable safety profile. Phase... Via Benzinga NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday March 05, 2024 U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Dow Dips Over 100 Points; Target Posts Upbeat Earnings March 05, 2024 U.S. stocks traded lower this morning, with the Dow Jones index falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.33% to 38,861.95 while the NASDAQ... Via Benzinga Topics Stocks Exposures US Equities < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
